Key result
Pre-PCI brachial-ankle pulse wave velocity shows no association with acute gain or late lumen loss.
Why the study?
Elevated baPWV predicts adverse outcomes after PCI, but its relation to quantitative angiographic outcomes of DES implantation is unknown.
Does pre-procedural brachial-ankle pulse wave velocity predict acute gain or late lumen loss in patients undergoing drug-eluting stent implantation?
Cohort (n=141)
Outcome assessors blinded
No
Does pre-procedural brachial-ankle pulse wave velocity predict acute gain or late lumen loss in patients undergoing drug-eluting stent implantation?
Answers are grounded in this paper and cite their sources.
Pre-procedural arterial stiffness (baPWV) does not provide independent lesion-level angiographic information to guide PCI optimization, reinforcing its role solely as a systemic risk marker.
Background/Objectives: Elevated brachial–ankle pulse wave velocity (baPWV) predicts adverse outcomes after percutaneous coronary intervention, but its relation to the quantitative angiographic outcomes of drug-eluting stent (DES) implantation is unknown. We examined baPWV against acute gain and late lumen loss. Methods: In a retrospective single-center cohort, 242 lesions in 141 patients with paired quantitative coronary angiography (QCA) were analyzed. baPWV was modeled per 1 SD with patient-level clustering (linear mixed model for acute gain; cluster-robust ordinary least squares for late lumen loss), with a Bonferroni-corrected α = 0.025 for the co-primary outcomes. Generalizability was assessed against registry patients without QCA. Results: An unadjusted inverse association with acute gain (β = −0.093 mm per 1 SD; p = 0.013) was fully attenuated after adjustment (β = −0.019; 95% CI −0.106 to +0.068; p = 0.67). baPWV was not associated with late lumen loss (adjusted β = −0.021; 95% CI −0.091 to +0.050; p = 0.57). Conclusions: Pre-procedural baPWV showed no independent association with acute gain or late lumen loss after DES implantation, consistent with a marker of systemic cardiovascular risk rather than independent local angiographic information. These data do not support using baPWV to guide procedural decisions.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) conducted a cohort in Patients undergoing drug-eluting stent implantation (n=141). Pre-procedural brachial-ankle pulse wave velocity (baPWV) was evaluated on Acute gain (immediate post-PCI minus pre-PCI minimum lumen diameter) (β = -0.019 mm per 1 SD, 95% CI -0.106 to +0.068, p=0.67). Pre-procedural brachial-ankle pulse wave velocity was not independently associated with acute gain or late lumen loss after drug-eluting stent implantation.
Synapse has enriched 10 related papers. Consider them for comparative context: